2m 2m 2m 2m 2m 2m 2m
LeMaitre Vascula (LMAT)
NASDAQ
$92.00+$0.05 (+0.05%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.0BMarket Cap
- 7.25%1-Year Change
- Medical Instruments & SuppliesIndustry
LeMaitre Vascula (LMAT)
$92.00+$0.05 (+0.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 249.6M +13.53% | 219.9M +13.63% | 193.5M +19.69% | 161.7M +4.68% | |
Cost of Revenue | 71.1M +3.05% | 69.0M +3.80% | 66.4M +17.06% | 56.8M +7.00% | |
Gross Profit | 178.5M +18.32% | 150.9M +18.77% | 127.0M +21.12% | 104.9M +3.47% | |
Sales and Marketing Expense | 54.5M +16.53% | 46.7M +13.84% | 41.1M +24.70% | 32.9M +19.04% | |
Research and Development Expense | -14.1M -9.65% | -15.7M -7.76% | -17.0M +27.62% | -13.3M +12.65% | |
Depreciation and Amortization Expense | 10.4M +7.74% | 9.7M +1.63% | 9.5M +0.87% | 9.4M -14.79% | |
Total Operating Expenses | 110.6M +12.15% | 98.6M +9.20% | 90.3M +15.72% | 78.1M +20.18% | |
Operating Profit | 67.9M +29.96% | 52.3M +42.34% | 36.7M +36.84% | 26.8M -26.34% | |
Interest Income | 13.1M +164.58% | 4.9M +60.84% | 3.1M +212.07% | 986,000 +400.51% | |
Interest Expense | -5.2M +2,428.78% | -205,000 N/A | 0 N/A | 0 +100.00% | |
Interest Income and Expense and Net | 7.9M +66.74% | 4.7M +54.18% | 3.1M +212.07% | 986,000 +148.76% | |
Total Nonoperating Income and Expense | -638,000 +410.40% | -125,000 -60.19% | -314,000 -3.38% | -325,000 -114.65% | |
Income before Taxes | 75.2M +32.19% | 56.9M +44.08% | 39.5M +43.60% | 27.5M -19.82% | |
Income Taxes | 17.4M +35.94% | 12.8M +37.00% | 9.4M +36.71% | 6.9M -7.13% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 57.7M +31.10% | 44.0M +46.28% | 30.1M +45.89% | 20.6M -23.31% | |
Net Income from Continuing Operations Applicable to Common | 75.2M +32.19% | 56.9M +44.08% | 39.5M +43.60% | 27.5M -19.82% | |
Basic EPS and Net Income | 2.55 +30.10% | 1.96 +44.12% | 1.36 +44.68% | 0.94 -25.98% | |
Diluted EPS and Net Income | 2.52 +30.57% | 1.93 +44.03% | 1.34 +44.09% | 0.93 -25.60% | |
Basic Weighted Average Shares | 22.6M +0.83% | 22.5M +1.06% | 22.2M +1.10% | 22.0M +3.87% | |
Diluted Weighted Average Shares | 22.9M +0.66% | 22.8M +1.59% | 22.4M +1.14% | 22.2M +3.24% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 28.2M +10.29% | 25.6M +5.53% | 24.3M +26.84% | 19.1M +38.10% | |
Short-Term Investments | 330.9M +20.71% | 274.1M +239.23% | 80.8M +27.14% | 63.6M +13.28% | |
Cash and Cash Equivalents and Short-Term Investments | 359.1M +19.82% | 299.7M +185.25% | 105.1M +27.07% | 82.7M +18.20% | |
Total Current Assets | 468.2M +16.42% | 402.2M +106.68% | 194.6M +20.32% | 161.7M +15.62% | |
Accumulated Depreciation | 28.4M +17.27% | 24.2M +12.70% | 21.5M -14.47% | 25.1M +9.56% | |
Property and Plant and Equipment and Net | 27.0M +8.86% | 24.8M +14.00% | 21.8M +21.52% | 17.9M +4.94% | |
Total Long-Term Assets | 4.9M +0.78% | 4.9M +30.16% | 3.7M +277.40% | 991,000 +74.47% | |
Total Assets | 615.7M +11.58% | 551.8M +59.13% | 346.8M +11.69% | 310.5M +6.04% | |
Income Taxes Payable | 1.7M +1,941.18% | 85,000 -20.56% | 107,000 +55.07% | 69,000 -1.43% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 36.3M +18.68% | 30.6M +2.44% | 29.9M +17.96% | 25.3M +16.12% | |
Total Long-Term Debt | 168.6M +0.52% | 167.8M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.5M +76.65% | 831,000 -63.36% | 2.3M +4.66% | 2.2M -19.77% | |
Total Liabilities | 222.2M +3.56% | 214.5M +338.90% | 48.9M +15.62% | 42.3M +9.38% | |
Retained Earnings | 184.7M +27.31% | 145.1M +25.70% | 115.4M +18.06% | 97.8M +10.95% | |
Total Stockholders Equity | 393.5M +16.67% | 337.3M +13.22% | 297.9M +11.07% | 268.2M +5.53% | |
Total Shares Outstanding | 22.8M -5.72% | 24.2M +1.01% | 23.9M +1.08% | 23.7M +0.76% | |
Cash Flow | |||||
Cash from Operating Activities | 81.3M +84.14% | 44.1M +20.06% | 36.8M +44.81% | 25.4M -27.70% | |
Capital Expenditures | 6.8M -2.57% | 7.0M -4.17% | 7.3M +124.99% | 3.2M -33.86% | |
Cash from Investing Activities | -64.9M -67.55% | -200.1M +709.71% | -24.7M +138.31% | -10.4M -83.02% | |
Dividends Paid | 18.1M +25.95% | 14.4M +15.50% | 12.4M +13.29% | 11.0M +17.69% | |
Cash from Financing Activities | -14.5M -109.20% | 158.1M +2,317.11% | -7.1M -22.77% | -9.2M -167.39% | |
Financials Ratio | |||||
Gross Margin | 71.53% +4.22% | 68.63% +4.52% | 65.66% +1.19% | 64.89% -1.16% | |
Operating Margin | 27.21% +14.48% | 23.77% +25.26% | 18.97% +14.32% | 16.60% -29.64% | |
Return on Assets | 9.89% +0.90% | 9.80% +6.99% | 9.16% +33.90% | 6.84% -30.64% | |
Return on Equity | 15.80% +13.95% | 13.87% +30.37% | 10.64% +34.61% | 7.90% -37.35% | |
Revenue Growth | 13.53% -0.79% | 13.63% -30.77% | 19.69% +320.78% | 4.68% -75.84% | |
Current Ratio | 12.89 -1.90% | 13.14 +101.76% | 6.51 +2.00% | 6.39 -0.43% | |
Cash Ratio | 0.78 -7.06% | 0.84 +3.02% | 0.81 +7.52% | 0.76 +18.92% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow